Olopatadine Hydrochloride and Mometasone Furoate Monohydrate
Indication
Adults and adolescents 12 years of age and older for the treatment of moderate to severe nasal symptoms associated with allergic rhinitis.
Black
Brand:
Ryaltris®
Nice TA:
Commissioning responsibility:
PbR excluded:
No
BNF chapter:
Ear
nose and oropharynx
Background
Recommendation
LSCMMG Recommendation:
Black
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria
Supporting documents: